[1]佟雷,林懿.外泌体在肿瘤诊疗中的研究进展[J].华侨大学学报(自然科学版),2023,44(3):281-289.[doi:10.11830/ISSN.1000-5013.202212015]
 TONG Lei,LIN Yi.Research Progress of Exosomes in Tumor Diagnosis and Treatment[J].Journal of Huaqiao University(Natural Science),2023,44(3):281-289.[doi:10.11830/ISSN.1000-5013.202212015]
点击复制

外泌体在肿瘤诊疗中的研究进展()
分享到:

《华侨大学学报(自然科学版)》[ISSN:1000-5013/CN:35-1079/N]

卷:
第44卷
期数:
2023年第3期
页码:
281-289
栏目:
出版日期:
2023-05-12

文章信息/Info

Title:
Research Progress of Exosomes in Tumor Diagnosis and Treatment
文章编号:
1000-5013(2023)03-0281-09
作者:
佟雷 林懿
华侨大学 医学院, 福建 泉州 362021
Author(s):
TONG Lei LIN Yi
College of Medicine, Huaqiao University, Quanzhou 362021, China
关键词:
肿瘤诊疗 外泌体 生物标志物 靶向治疗
Keywords:
tumor diagnosis and treatment exosome biomarker targeted therapy
分类号:
R730
DOI:
10.11830/ISSN.1000-5013.202212015
文献标志码:
A
摘要:
综述外泌体调控各类型肿瘤生物学行为特性,介绍外泌体在肿瘤诊疗中的研究进展,为外泌体在肿瘤精准诊疗领域中的应用提供理论依据.结果表明:外泌体广泛分布于肿瘤患者的血浆、尿液、唾液等各种体液中,来源于外泌体的核酸、蛋白质可介导不同类型肿瘤的生物学行为,在人体内的表达异常或可作为肿瘤早期诊断和预后评估的潜在生物标志物;对外泌体进行加工修饰后,产物可用于肿瘤疫苗制备和靶向药物研发.
Abstract:
In order to provide theoretical basis for the application of exosomes in the field of precise diagnosis and treatment of tumors, the regulation of exosomes on the biological behavior of each type of tumors is summarized, and the research progress of exosomes in tumor diagnosis and treatment is introduced. The results show that exosomes are widely distributed in each kind of fluid of tumor patients, such as plasma, urine, and saliva. Nucleic acids and proteins from exosomes can mediate the biological behavior of different type tumors, and their abnormal expression in humans may be used as potential biomarkers for early diagnosis and prognosis evaluation of tumors. After processing and modifying the exosomes, the product can be used for tumor vaccine preparation and targeted drug research and development.

参考文献/References:

[1] LI Rongkun,WANG Yahui,ZHANG Xiaoxin,et al.Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis[J].Molecular Cancer,2019,18:18.DOI:10.1186/s12943-019-0948-8.
[2] ZHANG Yi,BI Jiayao,HUANG Jiayi,et al.Exosome: A review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications[J].International Journal of Nanomedicine,2020,15:6917-6934.DOI:10.2147/ijn.s264498.
[3] JOHNSTONE R M.The jeanne manery-fisher memorial lecture 1991: Maturation of reticulocytes: Formation of exosomes as a mechanism for shedding membrane proteins[J].Biochemistry and Cell Biology,1992,70(3/4):179-190.DOI:10.1139/o92-028.
[4] MAO Liang,LI Xue,GONG Shu,et al.Serum exosomes contain ECRG4 mRNA that suppr-esses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis[J].Cancer Gene Therapy,2018,25(9/10):248-259.DOI:10.1038/s41417-018-0032-3.
[5] ZHAO Xiaoyin,WU Dongliang,MA Xudong,et al.Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake[J].Biomedicine & Pharmacotherapy,2020,128:110237.DOI:10.1016/j.biopha.2020.110237.
[6] MA Min,CHEN Shilin,LIU Zhuo,et al.MiRNA-221 of exosomes originating from bone marrow mesenchymal stem cells promotes oncogenic activity in gastric cancer[J].Oncotargets and Therapy,2017,10:4161-4171.DOI:10.2147/ott.s143315.
[7] WANG Liyan,BO Xiaotong,YI Xiaoyuan,et al.Exosome-transferred LINC01559 promotes the progression of gastric cancer via PI3K/AKT signaling pathway[J].Cell Death & Disease,2020,11(9):723.DOI:10.1038/s41419-020-02810-5.
[8] RONG Dawei,LU Chen,ZHANG B,et al.CircPSMC3 suppresses the proliferation and metastasis of gastric cancer by acting as a competitive endogenous RNA through sponging miR-296-5p[J].Molecular Cancer,2019,18(1):25.DOI:10.1186/s12943-019-0958-6.
[9] LIU Tong,ZHANG Xin,DU Lutao,et al.Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer[J].Molecular Cancer,2019,18(1):43.DOI:10.1186/s12943-019-0981-7.
[10] WANG Fengwei,CAO Chenhui,HAN Kai,et al.APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production[J].The Journal of Clinical Investigation,2019,129(2):727-743.DOI:10.1172/jci122478.
[11] SHANG Anquan,GU Chenzheng,WANG Weiwei,et al.Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis[J].Molecular Cancer,2020,19(1):117.DOI:10.1186/s12943-020-01235-0.
[12] QI Yongjian,ZHA Wangjian,ZHANG Wei.Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer[J].Journal of BUON: Official Journal of the Balkan Union of Oncology,2019,24(2):599-607.
[13] YANG Xin,CHEN Yan,ZHOU You,et al.GPC5 suppresses lung cancer progression and metastasis via intracellular CTDSP1/AhR/ARNT signaling axis and extracellular exosome secretion[J].Oncogene,2021,40(25):4307-4323.DOI:10.1038/s41388-021-01837-y.
[14] ZHANG Kaiwen,LIU Dong,ZHAO Jianmei,et al.Nuclear exosome HMGB3 secreted by nasopharyngeal carcinoma cells promotes tumour metastasis by inducing angiogenesis[J].Cell Death & Disease,2021,12(6):554.DOI:10.1038/s41419-021-03845-y.
[15] PATEL G K,DUTTA S,SYED M M,et al.TBX2 drives neuroendocrine prostate cancer through exosome-mediated repression of miR-200c-3p[J].Cancers(Basel),2021,13(19):5020.DOI:10.3390/cancers13195020.
[16] WU Jianhong,SUN Kening,CHEN Zhihao,et al.Exosome-mediated miR-4792 transfer promotes bladder cancer cell proliferation via enhanced FOXC1/c-Myc signaling and warburg effect[J].Journal of Oncology,2022,2022:5680353.DOI:10.1155/2022/5680353.
[17] CHEN Xin,CHEN Rixin,WEI Wensu,et al.PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition[J].Clinical Cancer Research,2018,24(24):6319-6330.DOI:10.1158/1078-0432.ccr-18-1270.
[18] SONG Wenbin,CHEN Yule,ZHU Guodong,et al.Exosome-mediated miR-9-5p promotes proliferation and migration of renal cancer cells both in vitro and in vivo by targeting SOCS4[J].Biochemical and Biophysical Research Communications,2020,529(4):1216-1224.DOI:10.1016/j.bbrc.2020.06.114.
[19] WU Xiangguang,ZHOU Chenfei,ZHANG Yanmei,et al.Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma[J].Angiogenesis,2019,22(3):397-410.DOI:10.1007/s10456-019-09665-1.
[20] HE Liuqing,ZHU Wei,CHEN Quan,et al.Ovarian cancer cell-secreted exosomal miR-205 promotes metastasis by inducing angiogenesis[J].Theranostics,2019,9(26):8206-8220.DOI:10.7150/thno.37455.
[21] GAO Xiaotong,WAN Zhuo,WEI Mengying,et al.Chronic myelogenous leukemia cells remodel the bone marrow niche via exosome-mediated transfer of miR-320[J].Theranostics,2019,9(19):5642-5656.DOI:10.7150/thno.34813.
[22] HAN Mingli,HU Jianguo,LU Pengwei,et al.Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer[J].Cell Death & Disease,2020,11(1):43.DOI:10.1038/s41419-020-2250-5.
[23] GARIKIPATI V N,VERMA S K,CHENG Zhongjian,et al.Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis[J].Nature Communications,2019,10(1):4317.DOI:10.1038/s41467-019-11777-7.
[24] GUO Xin,Lü Xiaohui,RU Yi,et al.Circulating exosomal gastric cancer-associated long noncoding RNA1 as a biomarker for early detection and monitoring progression of gastric cancer: A multiphase study[J].JAMA Surgery,2020,155(7):572-579.DOI:10.1001/jamasurg.2020.1133.
[25] TANG Weiwei,FU Kai,SUN Handong,et al.CircRNA microarray profiling identifies a novel circulating biomarker for detection of gastric cancer[J].Molecular Cancer,2018,17(1):137.DOI:10.1186/s12943-018-0888-8.
[26] YOON J,HAM I,KIM O,et al.Gastrokine 1 protein is a potential theragnostic target for gastric cancer[J].Gastric Cancer,2018,21(6):956-967.DOI:10.1007/s10120-018-0828-8.
[27] WANG Mei,QIU Rong,YU Shaorong,et al.Paclitaxel-resistant gastric cancer MGC-803 cells promote epithelial-to-mesenchymal transition and chemoresistance in paclitaxel sensitive cells via exosomal delivery of miR1555p[J].International Journal of Oncology,2019,54(1):326-338.DOI:10.3892/ijo.2018.4601.
[28] LI Jian,CHEN Yuxiang,GUO Xiong,et al.GPC1 exosome and its regulatory miRNAs are specific markers for the detection and target therapy of colorectal cancer[J].Journal of Cellular and Molecular Medicine,2017,21(5):838-847.DOI:10.1111/jcmm.12941.
[29] WANG Dong,WANG Xiaohui,SI Mahan,et al.Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages[J].Cancer Letters,2020,474:36-52.DOI:10.1016/j.canlet.2020.01.005.
[30] LIU Lin,MENG Tao,YANG Xinhui,et al.Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion[J].Cancer Biomark,2018,22(2):283-299.DOI:10.3233/cbm-171011.
[31] LI Yanyan,ZHANG Yuan,QIU Feng,et al.Proteomic identification of exosomal LRG1: A potential urinary biomarker for detecting NSCLC[J].Electrophoresis,2011,32(15):1976-1983.DOI:10.1002/elps.201000598.
[32] ZANG Xueyan,GU Jianmei,ZHANG Jiayin,et al.Exosome-transmitted lncRNA UFC1 promotes non-small-cell lung cancer progression by EZH2-mediated epigenetic silencing of PTEN expression[J].Cell Death & Disease,2020,11(4):215.DOI:10.1038/s41419-020-2409-0.
[33] CLARK D J,FONDRIE W E,YANG A,et al.Triple SILAC quantitative proteomic analysis reveals differential abundance of cell signaling proteins between normal and lung cancer-derived exosomes[J].Journal of Proteomics,2016,133:161-169.DOI:10.1016/j.jprot.2015.12.023.
[34] WU Shaocong,LUO Min,KENNETH K,et al.Intercellular transfer of exosomal wild type EGFR triggers osimertinib resistance in non-small cell lung cancer[J].Molecular Cancer,2021,20(1):17.DOI:10.1186/s12943-021-01307-9.
[35] WANG Yuhui,JI Jia,WANG Bicheng,et al.Tumo-derived exosomal long noncoding RNAs as promising diagnostic biomarkers for prostate cancer[J].Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology,2018,46:532-545.DOI:10.1159/000488620.
[36] FUJITA K,NONOMURA N.Urinary biomarkers of prostate cancer[J].International Journal of Urology(Official Journal of the Japanese Urological Association),2018,25(9):770-779.DOI:10.1111/iju.13734.
[37] YU Lijuan,SUI Bingdong,FAN Weixiao,et al.Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p[J].Journal of Extracellular Vesicles,2021,10(3):e12056.DOI:10.1002/jev2.12056.
[38] CHOU R,GORE J,BUCKLEY D,et al.Urinary biomarkers for diagnosis of bladder cancer: A systematic review and meta-analysis[J].Annals of Internal Medicine,2015,163(12):922-931.DOI:10.7326/m15-0997.
[39] ABBASTABAR M,SARFI M,GOLESTANI A,et al.Tumor-derived urinary exosomal long non-coding RNAs as diagnostic biomarkers for bladder cancer[J].Excli Journal,2020,19:301-310.DOI:10.17179/excli2019-1683.
[40] ZHANG Shujun,DU Lutao,WANG Lishui,et al.Evaluation of serum exosomal lncRNA-based biomarker panel for diagnosis and recurrence prediction of bladder cancer[J].Journal of Cellular and Molecular Medicine,2019,23(2):1396-1405.DOI:10.1111/jcmm.14042.
[41] GüLLü A,TINAY I,FILINTE D,et al.Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls[J].International Urology and Nephrology,2020,52(3):461-468.DOI:10.1007/s11255-019-02328-6.
[42] YAN Liang,LI Qi,SUN Ke,et al.MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1[J].American Journal of Translational Research,2020,12(10):6277-6289.
[43] PAN C,STEVIC I,MüLLER V,et al.Exosomal microRNAs as tumor markers in epithelial ovarian cancer[J].Molecular Oncology,2018,12(11):1935-1948.DOI:10.1002/1878-0261.12371.
[44] YOSHIDA K,YOKOI A,KATO T,et al.The clinical impact of intra-and extracellular miRNAs in ovarian cancer[J].Cancer Science,2020,111(10):3435-3444.DOI:10.1111/cas.14599.
[45] QIAN Mingyu,WANG Shaobo,GUO Xiaofan,et al.Hypoxic glioma-derived exosomes deliver microRNA-1246 to induce M2 macrophage polarization by targeting TERF2IP via the STAT3 and NF-κB pathways[J].Oncogene,2020,39(2):428-442.DOI:10.1038/s41388-019-0996-y.
[46] RISHA Y,MINIC Z,GHOBADLOO S,et al.The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers[J].Scientific Reports,2020,10(1):13572.DOI:10.1038/s41598-020-70393-4.
[47] TANG Xiangjun,SUN Xuyong,HUANG Kuanming,et al.Therapeutic potential of CAR-T cell-derived exosomes: A cell-free modality for targeted cancer therapy[J].Oncotarget,2015,6(42):44179-44190.DOI:10.18632/oncotarget.6175.
[48] FEDERICI C,SHAHAJ E,CECCHETTI S,et al.Natural-killer-derived extracellular vesicles: Immune sensors and interactors[J].Frontiers in Immunology,2020,11:262.DOI:10.3389/fimmu.2020.00262.
[49] WU Shuwei,LI Lei,WANG Yan,et al.CTL-derived exosomes enhance the activation of CTLs stimulated by low-affinity peptides[J].Frontiers in Immunology,2019,10:1274.DOI:10.3389/fimmu.2019.01274.
[50] ZHANG Haifeng,XIE Yufeng,LI Wei,et al.CD4(+)T cell-released exosomes inhibit CD8(+)cytotoxic T-lymphocyte responses and antitumor immunity[J].Cellular & Molecular Immunology,2011,8(1):23-30.DOI:10.1038/cmi.2010.59.
[51] SHARMA A,JOHNSON A.Exosome DNA: Critical regulator of tumor immunity and a diagnostic biomarker[J].Journal of Cellular Physiology,2020,235(3):1921-1932.DOI:10.1002/jcp.29153.
[52] ZHU Liya,KALIMUTHU S,GANGADARAN P,et al.Exosomes derived from natural killer cells exert therapeutic effect in melanoma[J].Theranostics,2017,7(10):2732-2745.DOI:10.7150/thno.18752.
[53] HAO Dexun,LI Yanshuang,ZHAO Gaofeng,et al.Soluble fms-like tyrosine kinase-1-enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration[J].Thoracic Cancer,2019,10(10):1962-1972.DOI:10.1111/1759-7714.13175.
[54] ZHOU Wenxi,ZHOU Yu,CHEN Xinli,et al.Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment[J].Biomaterials,2021,268:120546.DOI:10.1016/j.biomaterials.2020.120546.
[55] WANG Jie,CHEN Peng,DONG Yue,et al.Designer exosomes enabling tumor targeted efficient chemo/gene/photothermal therapy[J].Biomaterials,2021,276:121056.DOI:10.1016/j.biomaterials.2021.121056.
[56] LI Chi,DONNINGER H,EATON J,et al.Regulatory role of immune cell-derived extracellular vesicles in cancer: The message is in the envelope[J].Frontiers in Immunology,2020,11:1525.DOI:10.3389/fimmu.2020.01525.
[57] EMAM S E,ANDO H,ABU L,et al.A novel strategy to increase the yield of exosomes(extracellular vesicles)for an expansion of basic research[J].Biological & Pharmaceutical Bulletin,2018,41(5):733-742.DOI:10.1248/bpb.b17-00919.
[58] ZHANG Lin,YU Dihua.Exosomes in cancer development, metastasis, and immunity[J].Biochimica et Biophysica Acta-Reviews on Cancer,2019,1871(2):455-468.DOI:10.1016/j.bbcan.2019.04.00.

备注/Memo

备注/Memo:
收稿日期: 2022-12-13
通信作者: 佟雷(1980-),女,副教授,博士,主要从事病毒与肿瘤相互关系的研究.E-mail:leitong007@163.com.
基金项目: 福建省自然科学基金资助项目(2022J01311); 华侨大学高层次人才引进资助项目(21BS104)
更新日期/Last Update: 2023-05-20